A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+47.09%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$215M
AUM Growth
+$215M
Cap. Flow
-$6.07M
Cap. Flow %
-2.82%
Top 10 Hldgs %
99.27%
Holding
13
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 33.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RNA
1
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$78.4M 36.44% 6,213,924
SUPN icon
2
Supernus Pharmaceuticals
SUPN
$2.53B
$39.3M 18.28% 3,600,000
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$36.2M 16.83% 1,240,912
DRNA
4
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$26.7M 12.4% 1,182,196
AMRN
5
Amarin Corp
AMRN
$311M
$14.2M 6.58% 8,087,486
CEMP
6
DELISTED
Cempra, Inc.
CEMP
$7.65M 3.55% 714,285
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
$4.67M 2.17% 2,335,218
RGLS
8
DELISTED
Regulus Therapeutics
RGLS
$2.63M 1.22% 327,350
ACHV icon
9
Achieve Life Sciences
ACHV
$152M
$2.23M 1.04% 603,740
HPTX
10
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.63M 0.76% 62,500
ANTH
11
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.49M 0.69% 437,994
ZLCS
12
DELISTED
ZALICUS INC COM NEW
ZLCS
$96K 0.04% 78,966
GWPH
13
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-102,200 Closed -$6.07M